Location: San Francisco, CA
CIK: 0001799883 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $360M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALXO | ALX ONCOLOGY HLDGS INC | 3,057,325 | $6.13M | 1.7% | $1.77 | 0.0% | COM | 00166B105 |
| RLYB | RALLYBIO CORP | 291,788 | $2.617M | 0.7% | $5.22 | 0.0% | COM | 75120L209 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VRDN | VIRIDIAN THERAPEUTICS INC | 736,595 | $22.92M | 6.4% | $17.93 | +72.0% | — | 92790C104 |
| ELVN | ENLIVEN THERAPEUTICS INC | 772,477 | $11.9M | 3.3% | $20.34 | +25.9% | — | 29337E102 |
| — | RALLYBIO CORP | 3,630,724 | $2.491M | 0.7% | $17.58 | — | — | 75120L100 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ERAS | ERASCA INC | 3,485,971 (-35.5%) | $56.4M (+180.5%) | 15.7% | $2.16 | +364.5% | COM | 29479A108 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TYRA | TYRA BIOSCIENCES INC | 1,029,298 | $39.42M | 10.9% | $15.46 | +95.6% | COM | 90240B106 |
| CAMP | CAMP4 THERAPEUTICS CORP | 5,869,091 | $25.88M | 7.2% | $5.03 | -7.2% | COM | 13463J101 |
| TRDA | ENTRADA THERAPEUTICS INC | 4,056,379 | $51.19M | 14.2% | $17.12 | — | COM | 29384C108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 580,945 | $23.08M | 6.4% | $11.45 | — | SPONSORED ADS | 152309100 |
| TECX | TECTONIC THERAPEUTIC INC | 606,660 | $18.75M | 5.2% | $16.21 | +30.1% | COM | 878972108 |
| EYPT | EYEPOINT INC | 1,050,000 | $13.53M | 3.8% | $9.03 | +68.5% | COM NEW | 30233G209 |
| ARTV | ARTIVA BIOTHERAPEUTICS INC | 2,353,304 | $15.16M | 4.2% | $11.59 | -61.9% | COM | 04317A107 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 3,947,913 | $9.238M | 2.6% | $4.25 | -38.5% | COM | 98943L107 |
| MPLT | MAPLIGHT THERAPEUTICS INC | 950,011 | $19.31M | 5.4% | $16.75 | +5.2% | COM | 56565P103 |
| SRZN | SURROZEN INC | 387,500 | $11.29M | 3.1% | $12.54 | +77.3% | COM NEW | 86889P208 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 497,270 | $15.77M | 4.4% | $32.09 | -20.8% | COM NEW | 15117B202 |
| BHVN | BIOHAVEN LTD | 738,972 | $6.252M | 1.7% | $26.32 | -55.3% | COM | G1110E107 |
| SKYE | SKYE BIOSCIENCE INC | 9,681,763 | $5.95M | 1.7% | $11.84 | -92.4% | COM NEW | 83086J200 |
| GHRS | GH RESEARCH PLC | 572,665 | $8.052M | 2.2% | $10.15 | +54.8% | ORDINARY SHARES | G3855L106 |
| PHVS | PHARVARIS N V | 797,600 | $22.53M | 6.3% | $19.05 | +40.4% | COM | N69605108 |
| SLN | SILENCE THERAPEUTICS PLC | 476,200 | $2.51M | 0.7% | $21.60 | — | ADS | 82686Q101 |
| TARA | PROTARA THERAPEUTICS INC | 1,369,782 | $7.137M | 2.0% | $4.20 | +47.2% | COM STK | 74365U107 |